MOTS-c Peptide – Research Vial 10 mg, 20 mg, 40 mg

MOTS-c identity and amino acid sequence

MOTS-c is a sixteen-residue peptide whose name refers to a mitochondrial open reading frame associated with 12S ribosomal RNA. The published human sequence is MRWQEMGYIFYPRKLR. Written with explicit terminal groups, the reference is H-Met-Arg-Trp-Gln-Glu-Met-Gly-Tyr-Ile-Phe-Tyr-Pro-Arg-Lys-Leu-Arg-OH. These identity details distinguish the unmodified reference peptide from an acetylated derivative, altered sequence or other mitochondrial-derived peptide.

PubChem provides the parent formula and average molecular weight below. Counterions, residual water and formulation ingredients are outside that molecular definition. A salt name appearing among database synonyms should not be treated as proof of the form supplied in a particular product. Establish the product's chemical form from the specification and lot documentation.

Mitochondrial and nuclear research context

Lee and colleagues' discovery paper investigated MOTS-c in cell systems and mice, linking the proposed short open reading frame to experiments on cellular metabolism. Kim and colleagues subsequently examined nuclear localization during metabolic stress. Their work used subcellular fractionation and immunofluorescence, alongside studies of nuclear gene regulation. These papers explain why MOTS-c appears in research on communication between cellular compartments.

The reported observations depend on the biological model, stress condition, detection method and comparison group. A localization measurement and a change in a metabolic endpoint answer different experimental questions. They do not demonstrate a predictable effect from a commercial vial, establish a human benefit or validate an unrelated preparation. Use the original methods when assessing whether a paper is relevant to a proposed laboratory question.

Sequence-sensitive analytical assessment

The reference contains two methionine residues and several aromatic residues, making chemical modification and detection method relevant subjects for analytical evaluation. That is a reason to inspect the actual chromatogram and mass data, not a claim about the rate of change or stability of this lot. A reported extra peak requires identification before it can be assigned to a particular modification.

LC-MS identity assessment should show the expected species, observed charge states and mass comparison. Sequence fragments can provide information beyond an intact mass alone. Separately review chromatographic purity and quantitative content. A matching parent ion does not determine the total peptide amount, and a percentage based on detected chromatographic peaks is not automatically a mass fraction of all material in the vial.

Document any disagreement between a reference value and the laboratory result before using that result in a comparison. Average molecular weight, monoisotopic mass and observed mass-to-charge ratio are different quantities; apparent numerical differences can reflect reporting conventions rather than a different peptide.

Vial sizes, formulation and handling history

The catalog offers nominal 10 mg, 20 mg and 40 mg research-vial selections. Those quantities are product-format labels, not different MOTS-c molecular identities. Check the selected size and formulation against the report rather than extending one submitted sample's result to every available option.

Retain the lot number, receipt condition, documented storage requirements and analytical sample history. Record whether reported quantities describe peptide, salt or total preparation. Preparation conditions and retest decisions belong to the laboratory's method and the material's supporting evidence. No universal expiry, solution stability or formulation composition is assigned by this reference.

Frequently asked questions

Related research materials

• SS-31 research powder